Bank of America’s Bicycle Therapeutics BCYC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.77M | Buy |
830,634
+267,075
| +47% | +$1.86M | ﹤0.01% | 3194 |
|
|
2025
Q1 | $4.78M | Buy |
563,559
+170,700
| +43% | +$1.45M | ﹤0.01% | 3245 |
|
|
2024
Q4 | $5.5M | Buy |
392,859
+7,994
| +2% | +$112K | ﹤0.01% | 2960 |
|
|
2024
Q3 | $8.71M | Buy |
384,865
+1,061
| +0.3% | +$24K | ﹤0.01% | 2731 |
|
|
2024
Q2 | $7.77M | Sell |
383,804
-13,008
| -3% | -$263K | ﹤0.01% | 2752 |
|
|
2024
Q1 | $9.88M | Sell |
396,812
-64,519
| -14% | -$1.61M | ﹤0.01% | 2549 |
|
|
2023
Q4 | $8.34M | Buy |
461,331
+455,035
| +7,227% | +$8.23M | ﹤0.01% | 2574 |
|
|
2023
Q3 | $126K | Sell |
6,296
-236
| -4% | -$4.74K | ﹤0.01% | 5271 |
|
|
2023
Q2 | $167K | Buy |
6,532
+613
| +10% | +$15.6K | ﹤0.01% | 5124 |
|
|
2023
Q1 | $126K | Buy |
5,919
+406
| +7% | +$8.64K | ﹤0.01% | 5368 |
|
|
2022
Q4 | $163K | Sell |
5,513
-3,613
| -40% | -$107K | ﹤0.01% | 5284 |
|
|
2022
Q3 | $212K | Sell |
9,126
-8,171
| -47% | -$190K | ﹤0.01% | 5151 |
|
|
2022
Q2 | $290K | Buy |
17,297
+14,187
| +456% | +$238K | ﹤0.01% | 5099 |
|
|
2022
Q1 | $136K | Buy |
3,110
+586
| +23% | +$25.6K | ﹤0.01% | 5927 |
|
|
2021
Q4 | $153K | Buy |
2,524
+368
| +17% | +$22.3K | ﹤0.01% | 5831 |
|
|
2021
Q3 | $90K | Sell |
2,156
-176
| -8% | -$7.35K | ﹤0.01% | 5900 |
|
|
2021
Q2 | $71K | Buy |
2,332
+1,269
| +119% | +$38.6K | ﹤0.01% | 5876 |
|
|
2021
Q1 | $31K | Buy |
1,063
+847
| +392% | +$24.7K | ﹤0.01% | 6074 |
|
|
2020
Q4 | $4K | Buy |
+216
| New | +$4K | ﹤0.01% | 6064 |
|